A case of recurrent IgG4-related disease successfully treated with belimumab after remission of systemic lupus erythematosus

Rheumatology (Oxford). 2022 Oct 6;61(10):e308-e310. doi: 10.1093/rheumatology/keac284.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Immunoglobulin G4-Related Disease* / drug therapy
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic* / complications
  • Lupus Erythematosus, Systemic* / drug therapy
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • belimumab